In one paragraphArticle in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Evelyn A BatesDrug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA.ORCID 0000-0002-4157-2481 Zachary A KippDrug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA.ORCID 0000-0001-7344-7469 Wang-Hsin LeeDrug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA.ORCID 0000-0001-5258-8318 Genesee J MartinezDrug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA.ORCID 0000-0002-4593-7708 Sally N PaussDrug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA.ORCID 0000-0002-7365-7172 Philipp E SchererTouchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0003-0680-3392 Terry D HindsDrug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA.ORCID 0000-0002-7599-1529 Funding
The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · YALE UNIVERSITY · 2025 to 2025
$2.4MPhysiological Role of Dedifferentiating Dermal Adipose TissueR01DK131537 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · 2023 to 2025
$1.5MA New Perspective on Leptin in Health and DiseaseR01DK127274 · UT SOUTHWESTERN MEDICAL CENTER · 2025 to 2025
$809kWhite Adipose Tissue Physiology, Mitochondrial Function and AdiponectinR01DK099110 · UT SOUTHWESTERN MEDICAL CENTER · 2025 to 2025
$624kNeurobehavioral mechanisms underlying xylazine and fentanyl co-use and withdrawalR01DA058933 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$497kAmerican Heart Association 25PRE1374495National Heart Lung and Blood Institute F31HL170972National Heart Lung and Blood Institute F31HL175979National Heart Lung and Blood Institute R01HL174521NIA NIH HHS P01AG051459NIDA NIH HHS R01DA058933NIDDK NIH HHS R01DK099110NIDDK NIH HHS R01DK121797NIDDK NIH HHS R01DK127274NIDDK NIH HHS R01DK131537NIDDK NIH HHS R01DK55758
6 · The paper itselfAbstract
BACKGROUND/
objectivesSignaling mediators of PPARγ influence pathways involved in adipogenesis, lipid storage, inflammation, energy-related processes, and glucose utilization. Recent research indicates that PPARγ coregulators, recruited or released during ligand binding, govern specific gene pathways. It was recently discovered that Gα
methodsTo explore Gα
resultsThe absence of Gα
conclusionsThese findings support Gα
Indexed as
coregulatorCRISPRdiabetesGPCRG protein-coupled receptorinflammationkinomemitochondrianuclear receptorobesity
Identifiers
PMID42346398
PMCPMC13304297
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390